China SXT Pharmaceuticals reported total assets of $34.75M and total liabilities of $5.05M for the quarter ended Mar 2026, up 50.3% year over year. This balance sheet covers 19 quarters of results from Dec 2017 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2017 | Mar2018 | Sep2018 | Dec2018 | Mar2019 | Sep2019 | Mar2020 | Sep2020 | Mar2021 | Sep2021 | Mar2022 | Sep2022 | Mar2023 | Sep2023 | Mar2024 | Sep2024 | Mar2025 | Sep2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current Assets | |||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 0.01M | 0.66M | 0.38M | 0.66M | 9.29M | 9.29M | 7.29M | 10.35M | 13.36M | 0.03M | 13.36M | 15.57M | 17.37M | 17.37M | 12.08M | 18.51M | 18.10M | 21.17M | 28.18M |
| Cash & Current Investments | 0.01M | 0.66M | 0.38M | 0.66M | 9.29M | 9.29M | 7.29M | 10.35M | 13.36M | 0.03M | 13.36M | 15.57M | 17.37M | 17.37M | 12.08M | 18.51M | 18.10M | 21.17M | 28.18M |
| Receivables - NetNet Receivables | 2.60M | 3.89M | 4.18M | 4.57M | 3.82M | 5.58M | 4.51M | 4.16M | 3.33M | 4.00M | 1.34M | 1.31M | 1.31M | 1.66M | 1.30M | 1.34M | 0.93M | ||
| Receivables - OtherOther Receivables | 0.57M | 0.94M | 0.94M | 0.13M | 3.50M | -3.59M | 0.46M | 1.27M | 2.98M | 0.29M | 2.75M | 0.23M | 0.08M | 1.10M | 0.42M | 1.36M | 2.07M | ||
| Receivables | 3.54M | 3.89M | 4.31M | 8.07M | 0.23M | 6.04M | 5.77M | 7.14M | 3.62M | 6.75M | 1.58M | 1.31M | 1.40M | 2.77M | 1.72M | 2.70M | 3.00M | ||
| Raw Materials | 0.35M | 0.34M | 0.60M | 0.19M | 0.24M | 0.32M | 0.35M | 0.44M | 0.30M | 0.28M | |||||||||
| Finished Goods | 0.62M | 0.62M | 0.58M | 0.59M | 0.45M | 0.55M | 0.60M | 0.45M | 0.51M | 0.64M | |||||||||
| Inventory | 1.27M | 1.07M | 1.01M | 0.85M | 0.89M | 0.87M | 0.86M | 0.84M | 1.02M | 0.63M | 0.53M | 0.49M | 0.79M | 0.87M | 0.83M | 0.75M | 0.78M | ||
| Current Deferred Tax AssetsCurrent Deferred Tax | 0.05M | ||||||||||||||||||
| Prepaid Assets | 0.91M | 0.73M | 707.34M | 2.02M | 4.62M | 2,174.23M | 1.86M | 1,816.64M | 0.86M | 1,040.04M | 0.23M | 137.98M | 0.03M | 0.22M | 0.32M | 0.31M | 0.37M | ||
| Current Assets | 6.10M | 6.55M | 15.59M | 17.54M | 19.64M | 22.06M | 23.23M | 11.66M | 22.45M | 12.36M | 19.52M | 13.50M | 14.23M | 21.99M | 21.30M | 26.04M | 34.51M | ||
| Non-Current Assets | |||||||||||||||||||
| Construction in Progress | 0.63M | 0.57M | 0.65M | 0.18M | 0.33M | 0.45M | 0.36M | 0.36M | 0.36M | 0.34M | 0.35M | ||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.86M | 0.78M | 1.16M | 1.76M | 1.57M | 1.46M | 1.43M | 1.30M | 1.23M | 1.01M | 0.96M | 0.81M | 0.33M | 0.23M | 0.18M | 0.15M | 0.12M | ||
| Long-Term Investments | 3.50M | ||||||||||||||||||
| Intangibles | 0.06M | 0.05M | 0.06M | 0.05M | 0.05M | 0.05M | 0.05M | 0.04M | 0.04M | 0.03M | 0.03M | 0.02M | 0.02M | 0.02M | 0.01M | 0.01M | 0.01M | ||
| Goodwill & Intangibles | 0.06M | 0.05M | 0.06M | 0.05M | 0.05M | 0.05M | 0.05M | 0.04M | 0.04M | 0.03M | 0.03M | 0.02M | 0.02M | 0.02M | 0.01M | 0.01M | 0.01M | ||
| Long-Term Deferred Tax | 0.01M | 0.01M | 0.01M | 0.11M | 0.02M | 0.32M | 0.04M | 0.03M | |||||||||||
| Other Non-Current Assets | 0.10M | 0.18M | 0.16M | -3.61M | 0.51M | 2.86M | -8.85M | 9.31M | 9.46M | 8.43M | 8.74M | 8.31M | 8.55M | 0.03M | 0.03M | 368.00 | |||
| Non-Current Assets | 1.56M | 1.45M | 1.88M | 5.50M | 2.07M | 1.98M | 11.31M | 11.01M | 11.09M | 9.82M | 10.03M | 1.09M | 8.89M | 9.01M | 0.37M | 0.31M | 0.24M | ||
| Assets | 7.66M | 7.95M | 17.47M | 23.05M | 21.70M | 24.04M | 34.55M | 22.67M | 33.55M | 22.18M | 29.55M | 14.59M | 23.13M | 31.00M | 21.66M | 26.35M | 34.75M | ||
| Liabilities | |||||||||||||||||||
| Current Liabilities | |||||||||||||||||||
| Accounts Payables | 2.41M | 2.00M | 1.69M | 1.96M | 1.94M | 1.36M | 3.05M | 1.49M | 1.48M | 1.56M | 1.38M | 1.32M | 1.28M | 1.66M | 1.16M | 0.53M | 0.50M | ||
| Notes Payables | 0.39M | 0.19M | 0.23M | 0.06M | 0.04M | 0.05M | 0.04M | 0.02M | 2.03M | 0.17M | 0.27M | 0.49M | 0.70M | 0.70M | 0.98M | 0.36M | |||
| Payables | 2.79M | 2.19M | 1.92M | 2.02M | 1.99M | 1.40M | 3.08M | 1.52M | 3.52M | 1.56M | 1.55M | 1.58M | 1.77M | 2.36M | 1.86M | 1.51M | 0.85M | ||
| Accumulated Expenses | 0.42M | 0.31M | 0.69M | 0.70M | 0.13M | 3.05M | 3.36M | 3.53M | 3.28M | 3.14M | 3.25M | 2.77M | 2.92M | 2.94M | 3.27M | 3.30M | |||
| Other Accumulated Expenses | 0.15M | 0.21M | 2.48M | 0.17M | 0.29M | 0.73M | 0.82M | 2.12M | 8.70M | 1.03M | 0.42M | 1.05M | 7.45M | 0.67M | 0.92M | 0.88M | |||
| Short term Debt | 0.03M | 4.94M | 6.64M | 0.01M | 1.21M | 0.01M | 0.02M | 0.02M | 0.01M | 0.01M | 0.00M | ||||||||
| Current Leases | 1.53M | 8.31M | 0.06M | 0.06M | |||||||||||||||
| Current Taxes | 0.87M | 1.16M | 1.06M | 1.03M | 0.99M | 1.32M | 1.16M | 1.18M | 1.17M | 1.07M | 1.10M | 1.04M | 1.05M | 1.09M | 1.03M | 1.04M | 0.00M | ||
| Current Deferred Revenue | 0.29M | 0.12M | 0.06M | 0.12M | 0.30M | 0.22M | 0.26M | 0.22M | 0.08M | 0.07M | 0.17M | 0.19M | 0.19M | 0.19M | 0.06M | 0.07M | 0.10M | ||
| Total Current Liabilities | 4.37M | 3.99M | 6.32M | 10.76M | 12.26M | 5.51M | 18.58M | 8.88M | 17.12M | 7.29M | 14.50M | 9.20M | 8.90M | 15.66M | 6.01M | 5.96M | 4.35M | ||
| Non-Current Liabilities | |||||||||||||||||||
| Non-Current Debt | 0.04M | 0.06M | 0.04M | 0.02M | 0.01M | 0.12M | 0.11M | 0.12M | 0.12M | 0.10M | 0.07M | 0.64M | |||||||
| Convertible Debt | 0.82M | ||||||||||||||||||
| Preferred Stock Liabilities | 0.29M | 55.38M | |||||||||||||||||
| Operating Leases | 0.25M | 0.20M | 0.18M | 0.18M | 0.12M | 0.09M | 0.05M | ||||||||||||
| Other Non-Current Liabilities | 0.08M | 0.07M | 0.11M | 0.10M | 0.47M | 0.48M | 0.12M | 0.11M | 0.11M | 0.15M | 0.21M | 0.22M | 0.05M | 0.02M | 0.02M | ||||
| Total Non-Current Liabilities | 0.04M | 0.87M | 0.04M | 0.02M | 0.01M | 8.40M | 17.34M | 7.52M | 0.37M | 0.31M | 0.29M | 0.30M | 0.21M | 0.16M | 0.70M | ||||
| Total Liabilities | 4.37M | 3.35M | 6.36M | 11.64M | 12.30M | 5.52M | 18.59M | 8.88M | 17.46M | 7.63M | 14.86M | 9.51M | 9.20M | 15.96M | 6.22M | 6.12M | 5.05M | ||
| Shareholder's Equity | |||||||||||||||||||
| Total Debt | 0.39M | 0.19M | 0.30M | 5.05M | 6.72M | 0.06M | 0.04M | 0.02M | 2.05M | 1.21M | 0.29M | 0.39M | 0.63M | 0.83M | 0.81M | 1.05M | 1.00M | ||
| Common Equity | 3.29M | 4.60M | 11.11M | 11.41M | 9.40M | 18.52M | 15.96M | 13.79M | 16.08M | 14.55M | 14.69M | 5.08M | 13.93M | 15.03M | 15.44M | 20.23M | 29.71M | ||
| Liabilities and Shareholders Equity | 7.66M | 7.95M | 17.47M | 23.05M | 21.70M | 24.04M | 34.55M | 22.67M | 33.55M | 22.18M | 29.55M | 14.59M | 23.13M | 31.00M | 21.66M | 26.35M | 34.75M | ||
| Retained Earnings | 1.54M | 2.54M | 3.08M | 0.74M | -7.20M | -5.82M | -9.95M | -13.04M | -15.69M | -17.18M | -21.61M | -31.31M | -24.71M | -25.51M | -28.02M | -34.38M | -34.22M | ||
| Preferred Shares | 0.02M | 0.02M | 0.02M | 1.45M | 4.35M | 44.53M |
Pull China SXT Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=SXTC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "SXTC", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/statements?ticker=SXTC&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();